Metraipolis › archive › dc_2ecd06102e6f

Adipokines at the Metabolic-Brain Interface: Therapeutic Modulation by Antidiabetic Agents and Natural Compounds in Alzheimer's Disease — Europe PMC PMID:41155642

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41155642
DOI
10.3390/ph18101527
License (as archived)
solo-consultazione
Archived
2026-11-09T09:51:09.915Z
SHA-256 of the archived text
b2528913e4cfff4f773573fb079af3efdc2485cd1a403e29e7e76d30c64f62b0
Stable URL of this page
https://metraipolis.com/documento/dc_2ecd06102e6f

How to cite

Adipokines at the Metabolic-Brain Interface: Therapeutic Modulation by Antidiabetic Agents and Natural Compounds in Alzheimer's Disease — Europe PMC PMID:41155642 — Europe PMC (en), https://europepmc.org/article/MED/41155642 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ecd06102e6f (Metraipolis archive dc_2ecd06102e6f, sha256 b2528913e4cfff4f773573fb079af3efdc2485cd1a403e29e7e76d30c64f62b0)
BibTeX
@misc{dc2ecd06102e6f,
  title = {Adipokines at the Metabolic-Brain Interface: Therapeutic Modulation by Antidiabetic Agents and Natural Compounds in Alzheimer's Disease — Europe PMC PMID:41155642},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155642},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ecd06102e6f; sha256 b2528913e4cfff4f773573fb079af3efdc2485cd1a403e29e7e76d30c64f62b0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155642. Agents can read the archived copy with the MCP tool read_document.